Ma‘lumki, dunyo miqyosida farmatsevtika korxonalarida ishlab chiqarilayotgan dori vositalarirting taxminan 50% i dorivor osimliklar xomashyosidan tayyorlanmoqda. Mutloq ko‘pchilik mamlakatlarda, shu jumladan, O‘zbekiston Respublikasida farmatsevtika sanoatini jadallik bilan rivojlanishi bunday korxonalarning dorivor osimliklar xom-ashyosiga bolgan talabni keskin ortishiga sabab bolmoqda tabiiy holda osuvchi dorivor osimliklar zaxiralarining chegaralanganligi tufayli farmatsevtika sanoati korxonalaming dorivor osimliklar xom-ashyosiga bolgan talabini, asosan, dorivor osimliklar ostirish orqaligina qondirish mumkin.
Злокачественные опухоли носоглотки у детей составляют 1-3% от всех злокачественных опухолей детского возраста и 10-12% от опухолей головы и шеи, а в структуре заболевания среди опухолевых заболеваний ЛОР-органов – составляют 25% [6, 9, 10].
N Karimov, M Gafur-Akhunov, F Khayitov, E Laktionova, L Koren, F Kakhkharova, D Nishonov, К Nuritdinov
The article presents cases of the renal vein and inferior vena cava involvement by a tumor conglomerate, diagnosed by computed tomography. In all cases, patients were examined for complaints not related to the re-vealed underlying pathology and not presumed prior to the examination. Clinical diagnosis was determined with the help of detectable signs of massive expansion of the diameter of the main vessels. Thrombus was demonstrated in the vascular lumen with additional enhancement of CT after intravenous injection of uro-graphic contrast material.
M Tillyashaikhov, L Koren, Е Boyko, N Rakhimov, B Aloev, Sh Khasanov
The aim of this work was to determine the long-term risks of venous thromboembolism (VTE) in patients with subsequent extraction of residual tumor thrombus and the effect of residual tumor thrombus on overall survival. The first aim was to determine the risk of VTE during a 2-year follow-up period. The second aim was the determination of the overall survival within 2 years.
In patients with residual tumor thrombus, the overall survival rate was lower than in patients with a fully resected tumor thrombus, or in those who did not have a tumor thrombus. Conclusions: the presence of residual tumor thrombus is an important risk factor for the development of VTE amid patients with renal cell carcinoma.
М Tillyashaykhov, E Boyko, А Otaboev, L Koren, N Raximov, Sh Xasanov, B Aloev